High materiality7/10
Spyre Therapeutics price target raised to $135 from $115 at Deutsche Bank
Why it may matterVerify against the original reporting
Bullish setup based on higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Deutsche Bank raises SYRE target to $135 from $115; current price $101.42; priceChangeSinceSignal -0.65.
- Target raised to $135; price $101.42 (down 0.65).
Key facts
- 01
Target: $135
- 02
Posted price: $101.42
- 03
Analyst firm: Deutsche Bank
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.